Skip to content

A clinical study for purified CD34+ cell and peripheral blood-derived mononuclear cell auto-transplantation in treating no-option critical limb ischemia

A clinical study for purified CD34+ cell and peripheral blood-derived mononuclear cell auto-transplantation in treating no-option critical limb ischemia

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800019401
Enrollment
Unknown
Registered
2018-11-09
Start date
2009-04-01
Completion date
Unknown
Last updated
2018-11-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Peripheral artery disease/critical limb ischemia

Interventions

Group 1:Intramuscular transplantation of purified CD34+ cells
Group 2:Intramuscular transplantation of peripheral blood mononuclear cell

Sponsors

Zhongshan Hospital, Fudan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1) male or female aged between 18 and 80 years; 2) diagnosis of limb ischemia due to vascular stenosis or vascular occlusion; 3) rest pain or tissue loss under the superior level of metatarsus (Rutherford class4 or5); 4) being anatomically unsuitable for surgery or an endovascular intervention or showing no improvement for at least 3 months following surgery or an endovascular intervention; 5) if present, unrelieved rest pain or a woundsize that was not reduced after at least 1 month of medical treatment; 6) complete baseline data and known status of survival, amputation, wound healing and rest pain relief at 6 months after transplantation; 7)A consent form been signed.

Exclusion criteria

Exclusion criteria: 1) serious health events <3 months before admission, including but not limited to a myocardial infarction, cerebral apoplexy, a pulmonary embolism, severe hepatic and renal dysfunction; 2) a diagnosis of malignancy at baseline.

Design outcomes

Primary

MeasureTime frame
Major amputation;Major amputation-free survival;Complete remission of critical limb ischemia;

Secondary

MeasureTime frame
Wound healing;Wong-Baker pain scale;Ankle-brachial index;Transcutaneous oxygen pressure;

Countries

China

Contacts

Public ContactWeiguo Fu

Zhongshan Hospital, Fudan University

fu.weiguo@zs-hospital.sh.cn+86 64041990

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Mar 4, 2026